U.S. investment in new treatments is often driven by market potential rather than medical necessity, deepening health disparities and costing lives. Researchers say these recommendations could help.The diseases causing the most suffering and death in the United States do not always attract investment in new treatments. That’s the disconnect exposed in a new report from […]
